scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Lyka Labs Ltd

Feedback
Lyka Labs Ltd

Lyka Labs Ltd (LYKALABS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 164,395
Mar 13, 2025 15:48 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹99.33
₹-1.02 (-1.02%)
₹98 Low
Today’s Performance
₹103.78 High
₹97.9 Low
52 Week’s Performance
₹176.59 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.02%
  • 1 Week -11.23%
  • 1 Month -20.34%
  • 3 Months -38.57%
  • 6 Months -35.90%
  • 1 Year -8.87%
  • 3 Years -10.91%
  • 5 Years 45.47%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 1.32
  • 52-Week Low (₹) 97.90
  • 52-Week High (₹) 176.59
  • Price-to-Book (X)* 3.58
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 86.39
  • Earnings Per Share (₹) 1.15
  • Sector Price Earning (X)* 32.46
  • Market Cap (₹ Cr.)* 354.51
  • * Vaues as of last close price

COMPETITORS

BT TV

Where to Invest in a Market Dip? Key Themes to Watch| Navneet Munot's 'RRR' & 'PAN' Theme 1:21 Where To Invest In A Market Dip? Key Themes To Watch | Navneet Munot's 'RRR' & 'PAN' Theme
Time To Reinvest? Expert's Insights On CPI Data, Dollar Index, And When To Start Investing Again 2:21 Time To Reinvest? Expert's Insights On CPI Data, Dollar Index, And When To Start Investing Again
Investing In Quality Stocks | Expert Reveals The Secrets To Identifying Top Picks 3:09 Investing In Quality Stocks | Expert Reveals The Secrets To Identifying Top Picks
Navneet Munot on Market Slowdown: Temporary or Trend?|FIIs Return|India vs China 2:13 Navneet Munot: 'India's fundamentals remain strong' despite recent FII outflows
Gold Vs. Uncertainty: Expert Insights On Investing In Gold Amidst Market Volatility 1:45 Gold Vs. Uncertainty: Expert Insights On Investing In Gold Amidst Market Volatility
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Nov 24, 2021 PURCHASE
IPCA LABORATORIES LIMITED
  • Qty 1800000
  • Average Price ₹130.40
Nov 24, 2021 Sell
MAYANK JASHWANTLAL SHAH
  • Qty 1800000
  • Average Price ₹130.40
Nov 24, 2021 Sell
SHRUTI MAYANK SHAH
  • Qty 1500000
  • Average Price ₹130.40
Nov 24, 2021 Sell
PRASHAM MAYANK SHAH
  • Qty 1500000
  • Average Price ₹130.40
Nov 24, 2021 PURCHASE
IPCA LABORATORIES LIMITED
  • Qty 1500000
  • Average Price ₹130.40
Nov 24, 2021 PURCHASE
IPCA LABORATORIES LIMITED
  • Qty 1500000
  • Average Price ₹130.40
Nov 23, 2021 Sell
AMEE PARIKH
  • Qty 975356
  • Average Price ₹124.20
Nov 23, 2021 PURCHASE
IPCA LABORATORIES LIMITED
  • Qty 975356
  • Average Price ₹124.20
Nov 23, 2021 Sell
DADAL&BROACHA STOCK BROKING PVT LTD
  • Qty 798786
  • Average Price ₹128.45
Nov 23, 2021 PURCHASE
IPCA LABORATORIES LIMITED
  • Qty 798786
  • Average Price ₹128.45
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Aug 25, 2022 PURCHASE
XTX MARKETS LLP
  • Qty 149216
  • Average Price ₹148.25
Aug 25, 2022 Sell
XTX MARKETS LLP
  • Qty 145633
  • Average Price ₹148.93
Aug 24, 2022 Sell
SUVARNA KUMARI AGRAWAL
  • Qty 270000
  • Average Price ₹138.31
Aug 24, 2022 PURCHASE
VEENA RAJESH SHAH
  • Qty 200542
  • Average Price ₹134.51
Aug 24, 2022 PURCHASE
CESTRUM CORPORATE ADVISORS LLP
  • Qty 300000
  • Average Price ₹138.27
Aug 24, 2022 PURCHASE
RIKEEN P DALAL HUF
  • Qty 380626
  • Average Price ₹138.25
Aug 24, 2022 Sell
VEENA RAJESH SHAH
  • Qty 200542
  • Average Price ₹136.41
Jun 20, 2022 Sell
SAHASRAR CAPITAL PRIVATE LIMITED
  • Qty 200000
  • Average Price ₹114.51
Feb 22, 2022 Sell
VORA FINANCIAL SERVICES PVT LTD
  • Qty 434859
  • Average Price ₹130.36
Feb 10, 2022 PURCHASE
GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED
  • Qty 160000
  • Average Price ₹161.50
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Lyka Labs Ltd share price previously?
Lyka Labs Ltd share price was down by -1.02% from the previous closing price of ₹100.35.
Who are peers of Lyka Labs Ltd?
The peers of Lyka Labs Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Lyka Labs Ltd?
The promotor/promotors of Lyka Labs Ltd are KUNAL NARENDRA GANDHI, Yogesh B Shah, Dhara P. Shah, Babulal Jain, Prashant Godha, Shashil Mendonsa, Shekhar R Singh.
What has been 52-week high of Lyka Labs Ltd stocks?
The highest price of Lyka Labs Ltd stock is ₹176.59 in the last 52-week.
What is the share price of Lyka Labs Ltd (LYKALABS) today on NSE?
As on Mar 13, 2025, Lyka Labs Ltd (LYKALABS)’s share price on NSE is Rs 99.33
What is the market cap of Lyka Labs Ltd (LYKALABS?)
The current market capitalisation of Lyka Labs Ltd (LYKALABS) is 354.51 crores
What is Lyka Labs Ltd Share symbol?
The symbol of Lyka Labs Ltd is LYKALABS.
What is the PE ratio of Lyka Labs Ltd (LYKALABS)?
The current PE ratio of Lyka Labs Ltd (LYKALABS) is 86.39.
What is the PB ratio of Lyka Labs Ltd (LYKALABS)?
The current PB ratio of Lyka Labs Ltd (LYKALABS) is 3.58.
Today’s High & Low share prices of Lyka Labs Ltd (LYKALABS) on NSE?
Today, the share price of Lyka Labs Ltd (LYKALABS) on NSE touched a high of Rs 103.78 and a low of Rs 98
What price did Lyka Labs Ltd (LYKALABS) shares open on the NSE today?
On NSE, the share price of Lyka Labs Ltd (LYKALABS) opened at Rs 101.79
What is the 52-week high of Lyka Labs Ltd (LYKALABS)?
The 52-week high price of Lyka Labs Ltd (LYKALABS) is Rs 176.59
What is the 52-week low of Lyka Labs Ltd (LYKALABS) ?
The 52-week low price of Lyka Labs Ltd (LYKALABS) is Rs 97.9

ABOUT LYKA LABS

Lyka Labs Ltd, incorporated in the year 1976, has its registered office in 4801/B & 4802/A, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002, 91-02646-221422/220549, 91-02646-250692. The main industry in which Lyka Labs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Lyka Labs Ltd is/are D Kothary & Co. In the main management, Babulal Jain is chairman and Shekhar R Singh is the company secretary for Lyka Labs Ltd.

  • KNG KUNAL NARENDRA GANDHI Managing Director & CEO
  • YBS Yogesh B Shah Executive Director & CFO
  • DPS Dhara P. Shah Non-Exec. & Independent Dir.
  • BJ Babulal Jain Chairman & Independent Directo
  • PG Prashant Godha Non Executive Director
  • SM Shashil Mendonsa Non Executive Director
  • SRS Shekhar R Singh Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement